Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Azn crawled time : 13:30 save search
GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: 0.51%
H: 2.49%
C: 1.37%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.45%
H: 0.55%
C: -0.24%
lung test cancer risk study
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published: 2024-01-08 (Crawled : 13:30) - prnewswire.com
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.71%
H: 0.36%
C: 0.11%
LEXX | $2.27 0.89% 0.88% 62K
|
Health Technology
|
| O: 0.0%
H: 8.15%
C: 1.48%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.37%
H: 1.09%
C: 0.75%
NVO | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.34%
C: 0.21%
MRK | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.32%
H: 0.26%
C: -0.18%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.28%
H: 0.99%
C: 0.93%
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce CUTX-101, Copper Histidinate, Data to be Presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Published: 2022-03-21 (Crawled : 13:30) - biospace.com/
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -4.79%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.03%
H: 0.66%
C: -5.96%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
cutx-101 america genetic therapeutics biotech iot
Therapeutics for Women's Health - A Comprehensive Industry Assessment Highlighting the Key Opportunities, Pricing & Reimbursement, Players, and Strategic Recommendations - Forecast to 2026
Published: 2022-03-11 (Crawled : 13:30) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: -2.32%
H: 2.3%
C: 0.22%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
ABBV | News | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.22%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
health therapeutics women
Idiopathic Pulmonary Fibrosis Market to Reach $6.16 Bn, Globally, by 2030 at 7.0% CAGR: Allied Market Research
Published: 2022-02-07 (Crawled : 13:30) - prnewswire.com
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.69%
H: 0.5%
C: -1.76%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 3.7%
H: 1.64%
C: 1.24%
GLPG | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 2.54%
H: 1.58%
C: 0.1%
FGEN | $1.15 -1.71% -1.74% 1.3M
|
Health Technology
|
| O: -1.09%
H: 9.3%
C: 8.82%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 2.54%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.14%
H: 1.01%
C: 0.87%
fibrosis research
Fortress Biotech Announces Initiation of Phase 2 Clinical Trial of Triplex for Adults Co-Infected with HIV and CMV
Published: 2021-12-16 (Crawled : 13:30) - globenewswire.com
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.5%
H: 1.71%
C: 1.71%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: -5.34%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 2.13%
H: 1.9%
C: 1.73%
phase 2 trial biotech iot hiv infections
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
Published: 2021-12-07 (Crawled : 13:30) - globenewswire.com
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -2.48%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 7.0%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.08%
H: 1.18%
C: 1.13%
new drug treatment application drug therapeutics disease biotech iot submission
Akoya Biosciences to Host Inaugural Spatial Day on December 15, 2021
Published: 2021-11-22 (Crawled : 13:30) - globenewswire.com
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: -0.1%
AKYA | $3.81 -1.04% -1.05% 170K
|
Professional, Scientific, and T...
|
| O: 6.15%
H: 2.32%
C: 1.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: 0.0%
bioscience
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.